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unlabelled antimalarial and radiolabelled drug (12). Samples were then centrifuged through 1 silicon oil (AnalaR, BDH), processed (12) and radioactivity was determined on a Beckman 2 liquid scintillation spectrometer. Uptake was represented as a percentage of control parasitized 3 erythrocytes minus uptake of drug in uninfected erythrocytes (± relative SD). All experiments 4
were repeated at least twice in triplicate. 5 
6
The sensitivities of eight laboratory parasite lines were assessed to a range of antimalarial drugs 7 (Table 1 Figure 1 ) was significantly reduced in all four lines by DHA (P < 0.001) and ATM (P ≤ 0.008). 19 However, in CQS FC27 and 3D7, ATM had a significantly weaker ability to reduce [ 3 H]-CQ 20 uptake compared to DHA (P < 0.001). In all lines, both unlabelled CQ and PPQ strongly reduced 21 and CQ support the above results (4, 11, 17) . 6 7 Competition for uptake of CQ and DHA at the same site (12) or competition for 8 ferriprotoporphyrin (FPIX), a by-product of hemoglobin breakdown, may lead to the observed 9 antagonism. As it was shown that CQ, AQ and PPQ reduce DHA accumulation, and vice versa 10 for CQ, it may be possible that this could be a contributing factor towards antagonism seen here. 11 CQ binds to FPIX extremely avidly (6) and this saturable CQ uptake into the digestive vacuole 12 has been proposed as the cause of intracellular accumulation of drug by the parasite (3). 13
Artemisinin reacts with FPIX to form an adduct (13, 14) and molecular modelling studies have 14 shown a stable docked configuration of artemisinin and FPIX could exist (15) . Bound DHA 15 might sterically protect the CQ from interacting with FPIX, which could cause a decrease in CQ 16 accumulation. Drugs which bind to FPIX have been shown to competitively inhibit CQ uptake 17 (2) . On the other hand, bound CQ would sterically protect FPIX from DHA interaction which 18 may protect FPIX from the free-radical producing reaction with artemisinins (22) 
